<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872322</url>
  </required_header>
  <id_info>
    <org_study_id>SRAI17D.481</org_study_id>
    <nct_id>NCT04872322</nct_id>
  </id_info>
  <brief_title>Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery</brief_title>
  <official_title>Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the increasing rise of outpatient surgery in orthopaedic procedures, the management of&#xD;
      immediate postoperative pain has been a major topic investigated, with the use of a&#xD;
      peripheral nerve block in combination with general anesthesia being a commonly accepted&#xD;
      method. Foot and ankle procedures, which offer the choice of several anesthetic techniques,&#xD;
      have increasingly been performed with this method predominantly through the combination of&#xD;
      general anesthesia with a single-injection popliteal nerve block to reduce the substantial&#xD;
      acute postoperative pain that often requires large opioid intake within the post-anesthesia&#xD;
      care unit (PACU). However, as a single-injection peripheral nerve block resolves off shortly&#xD;
      following surgery, major postoperative pain, termed &quot;rebound pain&quot;, can also arise, and has&#xD;
      the potential to be even greater than that of patients who do not receive any peripheral&#xD;
      nerve block with general anesthesia.&#xD;
&#xD;
      The purpose of this study is to evaluate the contribution of ropivacaine concentration (0.5%&#xD;
      versus 0.25%) of the initial bolus in continuous popliteal nerve blocks toward the rebound&#xD;
      pain phenomena, or the quantifiable difference in pain experienced during the initial time&#xD;
      after block resolution, in foot and ankle surgeries.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 31, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>7 days</time_frame>
    <description>Participants Satisfaction with pain control will be measured using the Visual Analog Scale for Pain (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Opioid Usage</measure>
    <time_frame>7 days</time_frame>
    <description>For each group, participants will be asked to record their postoperative pain medication usage daily</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Popliteal Nerve Block</condition>
  <condition>Foot Surgery</condition>
  <condition>Ankle Surgery</condition>
  <arm_group>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants undergoing foot or ankle surgery will receive an initial injection of 0.5% ropivacaine as the initial anesthetic followed by continuous injection of 0.25% ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partial Popliteal Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants undergoing foot or ankle surgery will receive 0.25% ropivacaine initially followed by the usual continuous injection of 0.25% ropivacaine during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% Injectable Solution</intervention_name>
    <description>Participants will receive the nerve block preoperatively using 0.5% ropivacaine</description>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.25% Injectable Solution</intervention_name>
    <description>Participants will receive the nerve block preoperatively using 0.25% ropivacaine</description>
    <arm_group_label>Partial Popliteal Nerve Block</arm_group_label>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Percocet Pill</intervention_name>
    <description>After surgery participants will be given a prescription for Percocet to be taken as needed for pain</description>
    <arm_group_label>Partial Popliteal Nerve Block</arm_group_label>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norco Pill</intervention_name>
    <description>After surgery participants will be given a prescription for Norco to be taken as needed for pain</description>
    <arm_group_label>Partial Popliteal Nerve Block</arm_group_label>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Foot/Ankle Surgery</intervention_name>
    <description>Participant will undergo foot or ankle surgery and receive a popliteal nerve block</description>
    <arm_group_label>Partial Popliteal Nerve Block</arm_group_label>
    <arm_group_label>Standard Popliteal Nerve Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients undergoing foot and ankle surgeries under the care of Dr. Steven Raikin&#xD;
             with continuous popliteal blocks at Riverview Surgical Center will be considered for&#xD;
             enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who present with a) known hypersensitivity to ropivacaine or to any local&#xD;
             anesthetic agent of the amide type,&#xD;
&#xD;
          -  Existing use of narcotics,&#xD;
&#xD;
          -  Pregnant women,&#xD;
&#xD;
          -  Individuals under the age of 18&#xD;
&#xD;
          -  Procedures involving any other forms of anesthesia other than general anesthesia with&#xD;
             a continuous popliteal nerve block.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedic Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

